ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
102.74
-5.75 (-5.30%)
Jul 10, 2026, 2:45 PM EDT - Market open

BIB Holdings Information

BIB is an equity ETF with a total of 261 individual holdings.

Total Holdings
261
Top 10 Percentage
160.69%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
69.83M
PE Ratio
n/a

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1n/aNASDAQ BIO INDEX SWAP BNP PARIBAS44.04%5,756
2n/aNASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA30.38%3,970
3n/aNASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA26.90%3,515
4n/aNASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL20.19%2,639
5n/aNASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE19.23%2,513
6n/aNASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG4.84%633
7VRTXVertex Pharmaceuticals Incorporated4.62%7,683
8AMGNAmgen Inc.4.24%10,207
9GILDGilead Sciences, Inc.3.76%25,574
10REGNRegeneron Pharmaceuticals, Inc.2.49%3,377
11ALNYAlnylam Pharmaceuticals, Inc.1.55%4,377
12RVMDRevolution Medicines, Inc.1.50%6,970
13MRNAModerna, Inc.1.21%13,016
14BIIBBiogen Inc.1.14%4,841
15ILMNIllumina, Inc.1.09%4,963
16ROIVRoivant Sciences Ltd.0.95%23,584
17ARGXargenx SE0.94%906
18RPRXRoyalty Pharma plc0.94%14,542
19INSMInsmed Incorporated0.90%7,109
20UTHRUnited Therapeutics Corporation0.86%1,392
21INCYIncyte Corporation0.86%6,552
22GHGuardant Health, Inc.0.83%4,349
23VTRSViatris Inc.0.73%38,187
24NBIXNeurocrine Biosciences, Inc.0.65%3,298
25ASNDAscendis Pharma A/S0.61%2,021
Showing 25 of 261 holdings
Subscribe to see the full list
As of Jul 6, 2026